MODULE – 21

Dr. Sohandas Shetty says Chronic urticaria continues to pose significant challenges despite advances in our understanding of its underlying mechanisms. Many patients experience persistent symptoms, impaired quality of life, and inadequate disease control with conventional therapies, highlighting important unmet clinical needs. The development of emerging biologics and targeted therapies is expanding treatment possibilities and bringing us closer to a personalized approach to care. As clinicians, it is essential to stay abreast of these evolving therapeutic options to optimize disease management and improve long-term outcomes for patients with chronic urticaria